CL vs COST: How Colgate-Palmolive and Costco Wholesale Compare (2026)
Last updated July 2026
Short answer
COST is the larger of the two ($430.88B market cap): the incumbent the market prices for continued execution (42.90x forward earnings, beta 0.87). CL is the smaller challenger ($74.10B), cheaper on forward earnings (22.85x): more room to run, but more to prove. The real question is which set of drivers you believe, and whether owning one (or both) leaves you over-concentrated.
CL vs COST: the tie-breaker metrics
Same yardstick, side by side (as of July 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.
| Metric | CL | COST | What it tells you |
|---|---|---|---|
| Market cap | $74.10B | $430.88B | Size. The larger name is the incumbent; the smaller has more room to grow and more to prove. |
| Forward P/E | 22.85 | 42.90 | Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up. |
| Trailing P/E | 35.89 | 48.80 | Valuation on the last 12 months. A big drop from trailing to forward means the market expects earnings to jump, so more growth is already in the price. |
| Beta | 0.32 | 0.87 | Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through. |
| Price vs 52-week range | 73% of range | 51% of range | Where today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why. |
| Price / book | 511.60 | 26.06 | How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price. |
Reading it: CL is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.
Before you buy: how CL and COST affect your concentration
The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. CL and COST share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.
This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined CL and COST exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.
What does Colgate-Palmolive (CL) do?
Colgate-Palmolive is a global consumer-staples company that makes everyday household and personal-care products. It is a worldwide leader in oral care, where its Colgate-branded toothpaste, toothbrushes, and mouthwash hold a leading global share, and it also sells personal care (soaps, body wash, deodorants under brands like Palmolive, Softsoap, Irish Spring, and Sanex), home care (dish and surface cleaners such as Palmolive and Ajax), and pet nutrition through its Hill's Pet Nutrition business (Science Diet and Prescription Diet). Colgate makes money by selling these branded, frequently repurchased products at scale across more than 200 countries and territories, with a particularly large presence in emerging markets. Its competitive advantages come from powerful brands, vast distribution, and pricing power on staple goods. Headquartered in New York City, Colgate is a defensive, dividend-paying company whose products people buy regardless of the economic cycle.
What does Costco Wholesale (COST) do?
Costco Wholesale operates a membership-based warehouse club chain. Members pay an annual fee (currently $65 for basic Gold Star, $130 for Executive) for access to Costco warehouses, where they can buy products at lower markups than traditional retailers. Costco operates approximately 900 warehouses globally, with the largest concentration in the United States plus meaningful presence in Canada, Mexico, the UK, Japan, South Korea, Taiwan, Australia, and other markets.
CL vs COST: how do they differ?
Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.
- CL drivers: Oral-care leadership and emerging markets; Hill's Pet Nutrition growth.
- COST drivers: Membership fee growth; International expansion.
Which fits which kind of investor
A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: Colgate's growth is structurally slow: it competes in mature, saturated staples categories where volume gains are hard to come by and much of recent revenue growth has come from price increases that may not persist. For COST, costco's premium valuation embeds high expectations for continued same-store sales growth and margin expansion.
CL or COST: which should you pick?
Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick CL if you believe its drivers more; COST if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the CL and COST guides.
CL vs COST: the full fundamentals
CL. Colgate trades at a premium consumer-staples multiple that reflects its defensive, recession-resistant cash flows, leading oral-care brands, the growth of Hill's, and a multi-decade dividend-raising record. The valuation premium is the market paying for stability and pricing power, balanced against the reality of slow underlying volume growth in mature categories.
COST. Costco trades at one of the highest P/E ratios in retail, reflecting the durable membership model, consistent same-store sales growth, and the long runway for international expansion. The premium is also driven by Costco being widely viewed as a quality compounder in retail. The valuation has compressed historically only during severe market drawdowns.
Headline figures (approximate, early 2026): CL shows revenue (ttm) ~$20 billion, operating margin ~20-21%, net income (ttm) ~$2.7 billion, dividend yield ~2-2.5% (Dividend King); COST shows revenue (ttm) ~$260 billion, operating margin ~3.5% (low, by design; membership fees are the profit lever), net income (ttm) ~$7.5 billion, eps (ttm) ~$17.00.
The bottom line: CL vs COST
CL and COST are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined CL and COST exposure against your real portfolio. It is not an investment adviser.
Investing in Colgate-Palmolive with AI
Connect the broker you already use and ask Walnut's AI how CL fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.
FAQ
What is the difference between CL and COST?
+
Colgate-Palmolive is a global consumer-staples company that makes everyday household and personal-care products. Costco Wholesale operates a membership-based warehouse club chain. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.
Is CL or COST the better stock?
+
Neither is universally better. COST is the larger incumbent; CL is the smaller challenger and looks cheaper on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.
Which is cheaper, CL or COST?
+
On forward P/E (as of July 2026), CL trades at 22.85x and COST at 42.90x, so CL is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.
Should you own both CL and COST?
+
Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.
What are the risks of CL vs COST?
+
CL: Colgate's growth is structurally slow: it competes in mature, saturated staples categories where volume gains are hard to come by and much of recent revenue growth has come from price increases that may not persist. It faces intense competition from Procter and Gamble, Unilever, and private-label brands, plus pressure from retailers. Heavy emerging-market exposure brings currency volatility that can erode reported results. Input-cost inflation, the rise of private label during cost-of-living squeezes, and the challenge of sustaining pricing without losing volume all weigh on the outlook. The defensive premium valuation can also compress when investors rotate toward higher-growth or cyclical names. COST: Costco's premium valuation embeds high expectations for continued same-store sales growth and margin expansion. Any consumer slowdown or competitive pressure from BJ's, Sam's Club, or Amazon would compress the multiple.
Related comparisons
Browse all stock comparisons.
Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell CL or COST; figures are approximate and dated (as of July 2026). Verify current data before investing.